Stock & Company Details
Travere Therapeutics Inc $TVTX
Price:
N/A
N/A
94M
$5B
52 Week High:
N/A
10 Day Average Volume:
N/A
-40.35
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
TVTX technical indicators
Latest Travere Therapeutics Inc (TVTX) indicator readings as of 2026-11-04.
TVTX's 14-day RSI is 47.2, in neutral territory. ADX reads 23.4, sitting between trending and range-bound. MACD (12, 26, 9) is -1.95, below the zero line.
Overview
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
Finance Bot
Ask your questions
Start by typing a question below.
